Skip to Main Content

Author Details

David Nicol
The Royal Marsden Hospital
1993
162
41
PMIDPaper TitleJournal TitlePublished Year
36258058The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer Centre.Ann Surg Oncol2023
37183161European Association of Urology Guidelines on Testicular Cancer: 2023 Update.Eur Urol2023
37436368Diagnosis, treatment, and survival from kidney cancer: real-world National Health Service England data between 2013 and 2019.BJU Int2023
37264224Characterisation of cell lines derived from prostate cancer patients with localised disease.Prostate Cancer Prostatic Dis2023
36882564Treatment de-escalation for stage II seminoma.Nat Rev Urol2023
36609639ASO Visual Abstract: The Cancer Hub Approach for Upper Gastrointestinal Surgery During COVID-19 Pandemic: Outcomes from a UK Cancer Centre.Ann Surg Oncol2023
36672404Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review.Cancers (Basel)2023
36890417The influence of procedural volume on short-term outcomes for robotic pancreatoduodenectomy-a cohort study and a learning curve analysis.Surg Endosc2023
34933813Surgical Safety of Deferred Cytoreductive Nephrectomy Following Pretreatment with Immune Checkpoint Inhibitor-based Dual Combination Therapy.Eur Urol Oncol2022
35509203Management of stage II seminoma: a contemporary UK perspective.Scott Med J2022
35543402Therapeutic lymphangiography for chylous ascites.BJU Int2022
35453608COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility.Biomedicines2022
35863988Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis.Eur Urol Oncol2022
34949820Spatial patterns of tumour growth impact clonal diversification in a computational model and the TRACERx Renal study.Nat Ecol Evol2022
35279732Minimally invasive retroperitoneal lymph node dissection for men with testis cancer: a retrospective cohort study of safety and feasibility.World J Urol2022
31530498A Decision Analysis Evaluating Screening for Kidney Cancer Using Focused Renal Ultrasound.Eur Urol Focus2021
33722419Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021.Eur Urol2021
34723218Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set.Eur Urol Open Sci2021
34295765Factors that influence patients' views on treatment decision-making in localised kidney cancer.Transl Androl Urol2021
34337537Features and Management of Late Relapse of Nonseminomatous Germ Cell Tumour.Eur Urol Open Sci2021
34002049Selection of metastasis competent subclones in the tumour interior.Nat Ecol Evol2021
34046937The 'hub and spoke model' for the management of surgical patients during the COVID-19 pandemic.Int J Health Plann Manage2021
33242245The role of CT chest in screening for asymptomatic COVID-19 infection in self-isolating patients prior to elective oncological surgery: findings from a UK Cancer Hub.Br J Radiol2021
32855306Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study.Gut2021
32442581Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.Ann Oncol2020
32702311Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study.Lancet Oncol2020
32529651Prostate-specific membrane antigen expression in melanoma metastases.J Cutan Pathol2020
32247586Transition from open and laparoscopic to robotic pancreaticoduodenectomy in a UK tertiary referral hepatobiliary and pancreatic centre - Early experience of robotic pancreaticoduodenectomy.HPB (Oxford)2020
30942927Urothelial carcinoma arising from the transplanted kidney: A single-center experience and literature review.Clin Transplant2019
31511187Expert Elicitation to Inform a Cost-Effectiveness Analysis of Screening for Renal Cancer.Value Health2019
29307509Two-years Postradiotherapy Biopsies: Lessons from MRC RT01 Trial.Eur Urol2018
29576375Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.Cancer Cell2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
29656895Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal.Cell2018
29656894Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.Cell2018
29656891Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal.Cell2018
27639792Paratesticular Sarcoma: Typical Presentation, Imaging Features, and Clinical Challenges.Urology2017
28410988Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.Immunity2017
28407225Meta-analysis of the prevalence of renal cancer detected by abdominal ultrasonography.Br J Surg2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
28779136Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma.Sci Rep2017
26428415Clean intermittent self-catheterization does not appear to be effective in the prevention of urethral stricture recurrence.Scand J Urol2016
25730763Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
26625217Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis.Br J Cancer2015
26503208Patients Who Receive Androgen Deprivation Therapy Risk Adverse Cognitive Changes.J Clin Oncol2015
26018901Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue.Nat Genet2015
25685299Lessons learnt in the management of primary invasive penile cancer in an Australian tertiary referral centre: clinical outcomes with a minimum 48 months follow-up study.Korean J Urol2015
25790038Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution.Nat Commun2015
24162257PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer.Clin Exp Metastasis2014
25302455Urological Society of Australia and New Zealand's alignment with the BJU International: a collaborative success magnified by a supplement journal.BJU Int2014
  • 1 - 50 of 162

Recommended Authors

Jamil S Syed
Yale School of Medicine
Career Start Year 2015
Number of shared co-authors 1
Riccardo Campi
Careggi University Hospital
Career Start Year 2014
Number of shared co-authors 2
Tristan Juvet
Lions Gate Hospital
Career Start Year 2013
Number of shared co-authors 4
Bhanu Prasad Venkatesulu
Loyola University, Illinois Edward Hines Veteran Affairs Hospital
Career Start Year 2011
Number of shared co-authors 0
Paul L Crispen
University of Florida
Career Start Year 2005
Number of shared co-authors 0
Amirali Salmasi
University of California San Diego
Career Start Year 2005
Number of shared co-authors 1
Shiva M Nair
University of Western Ontario
Career Start Year 2005
Number of shared co-authors 0
Ithaar H Derweesh
university of california san diego School of Medicine
Career Start Year 2000
Number of shared co-authors 0
Surena F Matin
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 2
Niall M Corcoran
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1997
Number of shared co-authors 25
David Robert Siemens
Queen's University
Career Start Year 1996
Number of shared co-authors 1
Omer Acar
University of Illinois at Chicago
Career Start Year 1996
Number of shared co-authors 0
Douglas S Scherr
New York-Presbyterian Hospital
Career Start Year 1994
Number of shared co-authors 1
Louis Lacombe
CHU de Quebec-Universite Laval
Career Start Year 1994
Number of shared co-authors 5
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 6
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 1993
Number of shared co-authors 17
Raymond S Lance
Washington State University Elson S. Floyd College of Medicine
Career Start Year 1992
Number of shared co-authors 1
Bernd Wullich
University Hospital Erlangen, Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)
Career Start Year 1989
Number of shared co-authors 0
Philip Cornford
Liverpool University Hospitals
Career Start Year 1988
Number of shared co-authors 3
Yong Hyun Park
James Buchanan Brady Urological Institute, Johns Hopkins School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Armen Aprikian
McGill University Health Centre, McGill University
Career Start Year 1987
Number of shared co-authors 13
Theo M de Reijke
Amsterdam University Medical Centers, University of Amsterdam
Career Start Year 1987
Number of shared co-authors 2
Franz Recker
PolyClinic St. Moritz/Scuol
Career Start Year 1986
Number of shared co-authors 4
Arnulf Stenzl
Eberhard Karls University of Tubingen
Career Start Year 1984
Number of shared co-authors 7
Yves Chr??tien
European Hospital Georges Pompidou, University of Paris Descartes
Career Start Year 1982
Number of shared co-authors 0
Joseph L Chin
University of Western Ontario
Career Start Year 1982
Number of shared co-authors 3
Hendrik Van Poppel
University Hospitals Leuven
Career Start Year 1981
Number of shared co-authors 5
Eric J Bergstralh
Mayo Clinic
Career Start Year 1980
Number of shared co-authors 1
Anthony J Costello
Royal Melbourne Hospital
Career Start Year 1974
Number of shared co-authors 12
Hartwig Huland
Martini-Klinik Prostate Cancer Center, University Hospital-Hamburg-Eppendorf
Career Start Year 1971
Number of shared co-authors 5

Collaborators

Judith A Clements
Co-authored papers 16
Steven Hazell
Royal Marsden NHS Foundation Trust
Co-authored papers 14
Charles Swanton
Francis Crick Institute
Co-authored papers 14
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Co-authored papers 5
Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust
Co-authored papers 5
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Co-authored papers 5
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 5
Andy G Lynch
University of St Andrews
Co-authored papers 5
Adam Butler
Wellcome Sanger Institute
Co-authored papers 5
Peter Van Loo
The Francis Crick Institute
Co-authored papers 5
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 5
Alan Thompson
The Royal Marsden NHS Foundation Trust
Co-authored papers 4
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Co-authored papers 4
Lucy Matthews
University of Oxford
Co-authored papers 4
Erik Mayer
Imperial Clinical Analytics
Co-authored papers 4
Vincent J Gnanapragasam
University of Cambridge
Co-authored papers 4
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 4
Naomi Livni
Royal Marsden NHS Foundation Trust
Co-authored papers 4
Jorge Zamora
Universidade de Santiago de Compostela
Co-authored papers 4
Charlie E Massie
University of Cambridge
Co-authored papers 4
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 4
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 4
Nening Dennis
Institute of Cancer Research
Co-authored papers 4
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
David Jones
Wellcome Sanger Institute
Co-authored papers 4
Sandra Edwards
The Institute of Cancer Research
Co-authored papers 4
Hayley C Whitaker
University College London
Co-authored papers 4
Zsofia Kote-Jarai
The Institute of Cancer Research
Co-authored papers 4
Hayley J Luxton
University College London
Co-authored papers 4
Barbara Kremeyer
University College London
Co-authored papers 4
Release 1.2